Anti-metastatic activity, chemotherapeutic enhancement and therapeutic potential of targeting Hsp90 with ganetespib in triple negative breast cancer

被引：0
|
作者：
Proia, D. A. [1 ]
Zhang, C. [1 ]
Sequeira, M. [1 ]
Jimenez, J-P [1 ]
He, S. [1 ]
Nagai, M. [1 ]
Acquaviva, J. L. [1 ]
Smith, D. L. [1 ]
Sang, J. [1 ]
El-Hariry, I. [1 ]
机构：
[1] Synta Pharmaceut, Lexington, MA USA
来源：
CANCER RESEARCH | 2013年 / 73卷
关键词：
D O I：
10.1158/0008-5472.SABCS13-PD5-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PD5-3
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Safety and efficacy of HSP90 inhibitor ganetespib for neoadjuvant treatment of stage II/III breast cancer
    Lang, Julie E.
    Forero-Torres, Andres
    Yee, Douglas
    Yau, Christina
    Wolf, Denise
    Park, John
    Parker, Barbara A.
    Chien, A. Jo
    Wallace, Anne M.
    Murthy, Rashmi
    Albain, Kathy S.
    Ellis, Erin D.
    Beckwith, Heather
    Haley, Barbara B.
    Elias, Anthony D.
    Boughey, Judy C.
    Yung, Rachel L.
    Isaacs, Claudine
    Clark, Amy S.
    Han, Hyo S.
    Nanda, Rita
    Khan, Qamar J.
    Edmiston, Kristen K.
    Stringer-Reasor, Erica
    Price, Elissa
    Joe, Bonnie
    Liu, Minetta C.
    Brown-Swigart, Lamorna
    Petricoin, Emanuel F.
    Wulfkuhle, Julia D.
    Buxton, Meredith
    Clennell, Julia L.
    Sanil, Ashish
    Berry, Scott
    Asare, Smita M.
    Wilson, Amy
    Hirst, Gillian L.
    Singhrao, Ruby
    Asare, Adam L.
    Matthews, Jeffrey B.
    Melisko, Michelle
    Perlmutter, Jane
    Rugo, Hope S.
    Symmans, W. Fraser
    van't Veer, Laura J.
    Hylton, Nola M.
    DeMichele, Angela M.
    Berry, Donald A.
    Esserman, Laura J.
    NPJ BREAST CANCER, 2022, 8 (01)
  • [32] Anti-metastatic and anti-proliferative activity of eugenol against triple negative and HER2 positive breast cancer cells
    Mashan L. Abdullah
    Mohamed M. Hafez
    Ali Al-Hoshani
    Othman Al-Shabanah
    BMC Complementary and Alternative Medicine, 18
  • [33] Doxazosin exerts anti-metastatic potential in triple-negative breast cancer via impairment of cancer stem-like features
    Kim, Seongjae
    Ko, Dongmi
    Seo, Juyeon
    Park, Soeun
    Park, Minsu
    Dal Nam, Kee
    Kang, Yong Koo
    Seock, So Ra
    Park, Jaeyoun
    Oh, Eunhye
    Jung, Eunsun
    Kim, Yoon-Jae
    Kim, Ji Young
    Seo, Jae Hong
    CANCER RESEARCH, 2023, 83 (07)
  • [34] Therapeutic potential of ERK5 targeting in triple negative breast cancer
    Jesus Ortiz-Ruiz, Maria
    Alvarez-Fernandez, Stela
    Parrott, Tracy
    Zaknoen, Sara
    Burrows, Francis J.
    Ocana, Alberto
    Pandiella, Atanasio
    Esparis-Ogando, Azucena
    ONCOTARGET, 2014, 5 (22) : 11308 - 11318
  • [35] The activity of prospective HSP90 inhibitors in breast cancer cells
    Khamidullina, A.
    Yastrebova, M.
    Tatarskiy, V.
    Khlebnicova, T.
    Scherbakov, A.
    Piven, Y.
    FEBS OPEN BIO, 2021, 11 : 315 - 315
  • [36] Safety and efficacy of HSP90 inhibitor ganetespib for neoadjuvant treatment of stage II/III breast cancer
    Julie E. Lang
    Andres Forero-Torres
    Douglas Yee
    Christina Yau
    Denise Wolf
    John Park
    Barbara A. Parker
    A. Jo Chien
    Anne M. Wallace
    Rashmi Murthy
    Kathy S. Albain
    Erin D. Ellis
    Heather Beckwith
    Barbara B. Haley
    Anthony D. Elias
    Judy C. Boughey
    Rachel L. Yung
    Claudine Isaacs
    Amy S. Clark
    Hyo S. Han
    Rita Nanda
    Qamar J. Khan
    Kristen K. Edmiston
    Erica Stringer-Reasor
    Elissa Price
    Bonnie Joe
    Minetta C. Liu
    Lamorna Brown-Swigart
    Emanuel F. Petricoin
    Julia D. Wulfkuhle
    Meredith Buxton
    Julia L. Clennell
    Ashish Sanil
    Scott Berry
    Smita M. Asare
    Amy Wilson
    Gillian L. Hirst
    Ruby Singhrao
    Adam L. Asare
    Jeffrey B. Matthews
    Michelle Melisko
    Jane Perlmutter
    Hope S. Rugo
    W. Fraser Symmans
    Laura J. van ‘t Veer
    Nola M. Hylton
    Angela M. DeMichele
    Donald A. Berry
    Laura J. Esserman
    npj Breast Cancer, 8
  • [37] Targeting KRAS-Mutant Non-Small Cell Lung Cancer with the Hsp90 Inhibitor Ganetespib
    Acquaviva, Jaime
    Smith, Donald L.
    Sang, Jim
    Friedland, Julie C.
    He, Suqin
    Sequeira, Manuel
    Zhang, Chaohua
    Wada, Yumiko
    Proia, David A.
    MOLECULAR CANCER THERAPEUTICS, 2012, 11 (12) : 2633 - 2643
  • [38] Ganetespib, a Novel Hsp90 Inhibitor in Patients With KRAS Mutated and Wild Type, Refractory Metastatic Colorectal Cancer
    Cercek, Andrea
    Shia, Jinru
    Gollub, Marc
    Chou, Joanne F.
    Capanu, Marinela
    Raasch, Pamela
    Reidy-Lagunes, Diane
    Proia, David A.
    Vakiani, Efsevia
    Solit, David B.
    Saltz, Leonard B.
    CLINICAL COLORECTAL CANCER, 2014, 13 (04) : 207 - 212
  • [39] Targeting HSP90 in breast cancer: Enchant-1 (NCT01677455) phase 2 proof of concept study of ganetespib in first-line treatment of women with metastatic breast cancer
    Cameron, David A.
    Spector, Neil
    Cortes, Javier
    Mano, Max S.
    Canon, Jean-Luc Re
    Hickish, Tamas
    Vandat, Linda T.
    Kim, Sung-Bae
    Gomez, Henry Leonidas
    El-Hariry, Iman
    Vukovic, Vojislav M.
    Sheldon, Emily H.
    Perez, Edith A.
    Awada, Ahmad
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [40] Therapeutic strategies for metastatic triple negative breast cancer
    Takano, Toshimi
    ANNALS OF ONCOLOGY, 2018, 29
12345